Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma E Russo

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Npj Mental Health Research|April 12, 2024
Technical and clinical considerations for electroencephalography-based biomarkers for major depressive disorderLeif Simmatis, Emma E Russo, Joseph Geraci, et al.
Eneuro|May 4, 2023
Evaluation and Validation of Commercially Available Dopamine Transporter AntibodiesEmma E Russo, Lola E Zovko, Reza Nazari, et al.
Neuroscience|August 20, 2024
Towards discovery and implementation of neurophysiologic biomarkers of Alzheimer's disease using entropy methodsLeif E R Simmatis, Emma E Russo, Yasemin Altug, et al.
Journal of Alzheimer'S Disease : JAD|March 18, 2025
EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progressionLeif Er Simmatis, Emma E Russo, Tayo Steininger, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLeif Er Simmatis, Emma E Russo, Tayo Steininger, et al.
Brain Imaging and Behavior|February 11, 2026
Resting-state motor network connectivity as a biomarker of Levodopa response in Parkinson's diseaseEmma E Russo, Leif E R Simmatis, Kevin Kadak, et al.
EMBO Molecular Medicine|February 16, 2026
Alpha-methyl-para-tyrosine and amphetamine ameliorate hyperactivity in a novel mouse model of dopamine transporter deficiency syndromeEmma E Russo, Ameneh Rezayof, Conner Wallace, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Npj Mental Health Research|April 12, 2024
Technical and clinical considerations for electroencephalography-based biomarkers for major depressive disorderLeif Simmatis, Emma E Russo, Joseph Geraci, et al.
Eneuro|May 4, 2023
Evaluation and Validation of Commercially Available Dopamine Transporter AntibodiesEmma E Russo, Lola E Zovko, Reza Nazari, et al.
Neuroscience|August 20, 2024
Towards discovery and implementation of neurophysiologic biomarkers of Alzheimer's disease using entropy methodsLeif E R Simmatis, Emma E Russo, Yasemin Altug, et al.
Journal of Alzheimer'S Disease : JAD|March 18, 2025
EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progressionLeif Er Simmatis, Emma E Russo, Tayo Steininger, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLeif Er Simmatis, Emma E Russo, Tayo Steininger, et al.
Brain Imaging and Behavior|February 11, 2026
Resting-state motor network connectivity as a biomarker of Levodopa response in Parkinson's diseaseEmma E Russo, Leif E R Simmatis, Kevin Kadak, et al.
EMBO Molecular Medicine|February 16, 2026
Alpha-methyl-para-tyrosine and amphetamine ameliorate hyperactivity in a novel mouse model of dopamine transporter deficiency syndromeEmma E Russo, Ameneh Rezayof, Conner Wallace, et al.
Pageof 1